STAT+: Pharmalittle: Pfizer touts study data for hemophilia drug; former Novartis execs cleared of bribery in Greece
A report by nonpartisan congressional researchers suggests there are at least some parts of the new drug pricing law that drugmakers cannot challenge.
Good morning, everyone, and how are you today? We are doing fine, thank you, especially since we had an extended holiday weekend on this side of the pond. Whether you
